NURON BIOTECH
Nuron Biotech Inc. develops specialty biologics and vaccines. Its product pipeline comprises central nervous system products, such as NU100, a recombinant human interferon beta-1b for the treatment of relapsing remitting multiple sclerosis; wound healing products, including NU200, a recombinant human epidermal growth factor product for healing diabetic foot ulcers and burns; and HibTITER, a conjugate vaccine. The company was founded in 2010 and is based in Exton, Pennsylvania.
NURON BIOTECH
Industry:
Biotechnology Health Care Medical
Founded:
2010-01-01
Address:
Exton, Pennsylvania, United States
Country:
United States
Website Url:
http://www.nuronbiotech.com
Total Employee:
11+
Status:
Active
Contact:
610-968-6700
Total Funding:
102.71 M USD
Technology used in webpage:
Amazon Amazon Virginia Region Amazon S3 CDN Amazon Elastic Load Balancing Amazon ELB North Virginia
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
ZS Pharma
ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.
Current Advisors List
Board_member
Current Employees Featured
Tracy Goeken Vice President of Clinical & Medical Affairs @ Nuron Biotech
Vice President of Clinical & Medical Affairs
Mark W. Ambrose Vice President of Quality @ Nuron Biotech
Vice President of Quality
Vijay Tammara Vijay Tammara @ Nuron Biotech
Vijay Tammara
Founder
Investors List
HealthCare Royalty Partners
HealthCare Royalty Partners investment in Private Equity Round - Nuron Biotech
HealthCare Royalty Partners
HealthCare Royalty Partners investment in Private Equity Round - Nuron Biotech
Official Site Inspections
http://www.nuronbiotech.com
- Host name: ec2-52-200-66-12.compute-1.amazonaws.com
- IP address: 52.200.66.12
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Nuron Biotech"
Nuron Biotech - Crunchbase Company Profile & Funding
Nuron Biotech Inc. develops specialty biologics and vaccines. Its product pipeline comprises central nervous system products, such as NU100, a recombinant …See details»
Nuron Biotech, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Www.nuronbiotech.com. Holding Company | 2010 | Pennsylvania, United States | 10-50 | www.nuronbiotech.com. Last update 23 Jan 2025. Overview. Pipeline. Deal. Translational …See details»
Nuron Biotech Inc - Company Profile and News - Bloomberg …
Company profile page for Nuron Biotech Inc including stock price, company news, executives, board members, and contact informationSee details»
Nuron Biotech Company Profile | Management and Employees List …
Www.nuronbiotech.com . Contact Information. Headquarters. 1 E Uwchlan Ave Ste 302, Exton, Pennsylvania, 19341, United States (610) 968-6700. Nuron Biotech Profile and History . Nuron …See details»
Nuron Biotech Inc Management Team | Org Chart - RocketReach
Nuron Biotech Inc employs 5 employees. The Nuron Biotech Inc management team includes Vijay Tammara (VP Regulatory Affairs), Hans Fritz (General Manager European Operations), and …See details»
Nuron Biotech - Products, Competitors, Financials, Employees ...
Headquarters Location. 1 East Uwchlan Avenue Suite 302. Exton, Pennsylvania, 19341, United States. 611-968-6700See details»
Nuron Biotech Inc. - Company Profile & Staff Directory - ContactOut
Nuron Biotech markets and develops vaccines for the prevention and treatment of infectious diseases. We have commercial operations in Europe and around the globe through which we …See details»
Nuron Biotech - VentureRadar
Nuron Biotech's lead drug candidate, NU100 (interferon beta-1b), is a new chemical entity currently in Phase 3 for patients with multiple sclerosis. Nuron's vaccine brands include …See details»
Nuron Biotech, Inc. Company Profile: Financials, Valuation ... - PrivCo
Nuron Biotech, Inc. is a privately-held company that operates in the biotechnology industry. Nuron Biotech, Inc. was founded in 2010 by Shankar Musunuri. Nuron Biotech, Inc. headquarters are …See details»
Nuron Biotech Inc.
Founded by veterans of Pfizer, Nuron Biotech Inc. is developing a recombinant human interferon beta-1 free of human serum albumin and the aggregates that set off an immune response. …See details»
Nextsource | Company Profile | Nuron Biotech
Explore the company profile of Nuron Biotech (nuronbiotech.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Nuron Biotech, Inc. Asset Profile - Preqin
Founded in 2010.Nuron Biotech, Inc., is based in US and is developing novel biologics and vaccines for the prevention and treatment of neurodegenerative and ...See details»
Nuron Biotech Venture Capital and Private Equity Financings - VC …
Www.nuronbiotech.com. Nuron Biotech is developing novel biologics and vaccines for the prevention and treatment of neurodegenerative and infectious diseases. Its team of industry …See details»
Nuron biotech inc Reviews | Read Client Reviews of Nuron biotech …
Nuron biotech inc Review Reviews 10. 4See details»
Nuron 2025 Company Profile: Valuation, Funding & Investors
Nuron General Information Description. Operator of a medical research company intended to provide scientific research facilities. The company's platform automates data organization, …See details»
Nuron Biotech Licenses HibTITER® Vaccine to Mitsubishi Tanabe …
Jan 13, 2012 EXTON, Pa.--(BUSINESS WIRE)-- Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has licensed its HibTITER® vaccine to Mitsubishi …See details»
Nuron acquires Pfizer's meningitis vaccine | Fierce Pharma
Dec 11, 2012 The startup purchased the Hib vaccine from Pfizer's Wyeth unit in 2011. The FDA previously approved the shot to reduce the incidence of Hib disease in children, but Wyeth put …See details»
What is Nuron Biotech? Company Culture, Mission, Values
See what employees say it's like to work at Nuron Biotech. Salaries, reviews, and more - all posted by employees working at Nuron Biotech.See details»
Nuron Biotech Expands Portfolio With License of Therapeutic and ...
Mar 8, 2012 Our lead drug candidate, NU100 (interferon beta-1b), is a new chemical entity currently in Phase 3 for patients with multiple sclerosis. www.nuronbiotech.com. Contacts …See details»
Nuron Biotech bags $80M deal to back vaccines ... - Fierce Biotech
Dec 20, 2012 The investment cash has been flowing into biotechnology this week. This morning Nuron Biotech joined the parade, announcing an $80 million deal designed to boost its work …See details»